These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20489800)

  • 21. [Australia antigen and viral hepatitis. Epidemiological study in blood donors].
    Mansueto S; Tedesco V; Migneco G
    G Mal Infett Parassit; 1971 Dec; 23(12):1137-40. PubMed ID: 5004898
    [No Abstract]   [Full Text] [Related]  

  • 22. Specific inactivation of viruses which can potentially contaminate blood products.
    Horowitz B
    Dev Biol Stand; 1991; 75():43-52. PubMed ID: 1794631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
    Erhabor O; Ejele OA; Nwauche CA
    Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-transfusion hepatitis, a serious clinical problem.
    Allen JG
    Calif Med; 1966 Apr; 104(4):293-9. PubMed ID: 5909643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood transfusion reactions.
    Shafer N; Wilkenfeld M; Shafer R
    Leg Med; 1980; ():207-20. PubMed ID: 7421388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Parenteral routes of transmission of Botkin's disease].
    Burlaĭ VV
    Vrach Delo; 1969 May; 5():134-5. PubMed ID: 5368867
    [No Abstract]   [Full Text] [Related]  

  • 27. [Several aspects of the epidemiology of infectious and serum hepatitis at the present time].
    Tareev EM; Shatrov II; Mastiukova IuN
    Sov Med; 1977 Feb; (2):40-6. PubMed ID: 67648
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis A infection and vaccination among Danish blood donors.
    Christensen PB; Homburg KM; Sørensen LT; Georgsen J
    Scand J Infect Dis; 2005; 37(2):127-30. PubMed ID: 15773034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis-associated antigen in Belgium.
    Desmyter J; Liu W
    Arch Belg Med Soc; 1971 Jan; 29(1):1-10. PubMed ID: 5095938
    [No Abstract]   [Full Text] [Related]  

  • 30. [Transfusion hepatitis and inoculation hepatitis in the laboratory].
    Stampfli K
    Med Lab (Stuttg); 1969 Aug; 22(8):178-86. PubMed ID: 5351057
    [No Abstract]   [Full Text] [Related]  

  • 31. Occult hepatitis B virus (HBV) infection in healthy blood donors.
    Duseja A; Sharma S; Subramanian PG; Agnihotri SK; Chakraborti A; Chawla Y
    Indian J Pathol Microbiol; 2003 Oct; 46(4):690-2. PubMed ID: 15025384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral hepatitis--the state of the art.
    Clowdus BF
    Med Trial Tech Q; 1974; 21(1):63-75. PubMed ID: 4138562
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of transmissible blood infections among blood donors at the University of Maiducuri Teaching Hospital, Maiduguri, Nigeria.
    Chikwem JO; Mohammed I; Okara GC; Ukwandu NC; Ola TO
    East Afr Med J; 1997 Apr; 74(4):213-6. PubMed ID: 9299819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The thymol turbidity test on donors' blood as a possible aid in control of the transmission of serum viral hepatitis.
    WEETH JB
    Brooklyn Hosp J; 1953; 11(4):193-7. PubMed ID: 13149941
    [No Abstract]   [Full Text] [Related]  

  • 35. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala.
    Mathai J; Sulochana PV; Satyabhama S; Nair PK; Sivakumar S
    Indian J Pathol Microbiol; 2002 Jul; 45(3):319-22. PubMed ID: 12785175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion-transmitted viral hepatitis.
    Mosley JW
    Clin Lab Med; 1982 Mar; 2(1):233-52. PubMed ID: 7186430
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk factors for hepatitis C virus infection among blood donors in northern Thailand.
    Thaikruea L; Thongsawat S; Maneekarn N; Netski D; Thomas DL; Nelson KE
    Transfusion; 2004 Oct; 44(10):1433-40. PubMed ID: 15383015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlling post-transfusion hepatitis: a proposal to publicize hepatitis rates of transfusion facilities.
    Finkelstein SN; Sapolsky HM
    Am J Law Med; 1979; 5(1):1-9. PubMed ID: 495608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Removal and inactivation of hepatitis A virus (HAV) during processing of factor VIII concentrates.
    Hamman J; Zou J; Horowitz B
    Vox Sang; 1994; 67 Suppl 1():72-6; discussion 77. PubMed ID: 8091742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.